Immix Biopharma, Inc. Quarterly Current Ratio in % from Q3 2022 to Q3 2024

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Immix Biopharma, Inc. quarterly Current Ratio history and growth rate from Q3 2022 to Q3 2024.
Immix Biopharma, Inc. Current Ratio for the quarter ending September 30, 2024 was 518 %, a 37.3% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	518	-308	-37.3%	Sep 30, 2024
Q2 2024	636	-415	-39.5%	Jun 30, 2024
Q1 2024	620	-854	-57.9%	Mar 31, 2024
Q4 2023	678	-1.51K	-69%	Dec 31, 2023
Q3 2023	825	-2.58K	-75.8%	Sep 30, 2023
Q2 2023	1.05K			Jun 30, 2023
Q1 2023	1.47K			Mar 31, 2023
Q4 2022	2.19K			Dec 31, 2022
Q3 2022	3.41K			Sep 30, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.